Semax and Selank are two short peptides widely studied in cognitive and neurological research. Often grouped together as nootropic or neuropeptide research compounds, they have distinct origins and proposed mechanisms. This guide compares the two and explains why purity is critical for reproducible neuroscience work. For laboratory research use only.
Semax vs Selank: Origins, Mechanisms, and Research Uses
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10) with a modified, stabilizing tail. In research models it is studied primarily for effects on brain-derived neurotrophic factor (BDNF), attention, memory, and neuroprotection following ischemic or oxidative stress, which has made it a frequent subject in cognitive and stroke-model neuroscience. Selank, by contrast, is a synthetic analog of the immunomodulatory peptide tuftsin and is most often investigated for anxiolytic and stress-modulating activity, with studies examining its influence on GABAergic signaling, serotonin balance, and inflammatory markers. Although researchers sometimes group the two as nootropic peptides, they answer different experimental questions: Semax leans toward cognition and neurotrophic signaling, while Selank leans toward anxiety, stress resilience, and immune modulation. Both are typically administered intranasally in published animal and clinical research from Eastern Europe, and both are studied strictly as research compounds rather than approved therapies in most regions. As with any neuropeptide work, results hinge on the integrity of the starting material, since even small impurities can confound delicate behavioral and biochemical endpoints. Every batch of Semax and Selank from Kynetide is third-party HPLC tested to 99%+ purity and ships with a full Certificate of Analysis and batch traceability. Both peptides from Kynetide are supplied strictly for in-vitro and laboratory research use only and are not drugs, supplements, or cosmetics, and are not intended for human or veterinary use.
